Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

A Trial on the Clinical and Socioeconomic Impact of Wearable Exoskeletons for Spinal Cord Injury Rehabilitation in the Spanish Healthcare System

NCT07036107 · ABLE Human Motion S.L. · Updated 27 Jan 2026

What is being tested
ABLE Exoskeleton; Conventional therapy
For
Spinal Cord Injury
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 70 years. About 80 people. The full rules are on the registry page.
Where
Spain (2 sites)
When
Starts or started 15 Jan 2026, ends 30 Sept 2027. Registered 25 June 2025.
Results
None posted yet.

In the researchers' words

This clinical trial aims to collect evidence on the clinical benefits and the socioeconomic impact of integrating a novel wearable powered lower-limb exoskeleton for gait rehabilitation in acute/subacute spinal cord injured individuals and to evaluate the efficiency of this technology to the current standard of care in the Spanish Healthcare System (SNS).. The main questions it aims to answer are: * Is robotic therapy for gait rehabilitation more effective and efficient than conventional therapy? * Does robotic therapy for gait rehabilitation reduce the burden on healthcare professionals and caregivers? * Does robotic therapy for gait rehabilitation reduce direct healthcare costs? * Does robotic therapy for gait rehabilitation reduce intervention-related costs? Researchers will compare a novel wearable powered lower-limb exoskeleton for gait rehabilitation to conventional therapy to see if the robotic exoskeleton is more effective and efficient in improving clinical benefits and to assess if it reduces the burden of healthcare professionals and caregivers, as well as healthcare and intervention-related costs. Participants will: * Be randomized on a 1:1 basis to receive rehabilitation treatment with either the robotic exoskeleton or conventional therapy for gait recovery, 3 times a week on non-consecutive days for 8 weeks (24-session program). * Undergo a pre- and…
ClinicalTrials.gov, NCT07036107

Sites

  • Hospital Nacional de ParapléjicosToledo, Castille-La Mancha, Spain
  • Hospital Universitario de Vall d'HebronBarcelona, Catalonia, Spain